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Abstract
Background: We recently described a new questionnaire to monitor mood called mood zoom (MZ). MZ comprises 6 items
assessing mood symptoms on a 7-point Likert scale; we had previously used standard principal component analysis (PCA) to
tentatively understand its properties, but the presence of multiple nonzero loadings obstructed the interpretation of its latent
variables.
Objective: The aim of this study was to rigorously investigate the internal properties and latent variables of MZ using an
algorithmic approach which may lead to more interpretable results than PCA. Additionally, we explored three other widely used
psychiatric questionnaires to investigate latent variable structure similarities with MZ: (1) Altman self-rating mania scale (ASRM),
assessing mania; (2) quick inventory of depressive symptomatology (QIDS) self-report, assessing depression; and (3) generalized
anxiety disorder (7-item) (GAD-7), assessing anxiety.
Methods: We elicited responses from 131 participants: 48 bipolar disorder (BD), 32 borderline personality disorder (BPD), and
51 healthy controls (HC), collected longitudinally (median [interquartile range, IQR]: 363 [276] days). Participants were requested
to complete ASRM, QIDS, and GAD-7 weekly (all 3 questionnaires were completed on the Web) and MZ daily (using a
custom-based smartphone app). We applied sparse PCA (SPCA) to determine the latent variables for the four questionnaires,
where a small subset of the original items contributes toward each latent variable.
Results: We found that MZ had great consistency across the three cohorts studied. Three main principal components were
derived using SPCA, which can be tentatively interpreted as (1) anxiety and sadness, (2) positive affect, and (3) irritability. The
MZ principal component comprising anxiety and sadness explains most of the variance in BD and BPD, whereas the positive
affect of MZ explains most of the variance in HC. The latent variables in ASRM were identical for the patient groups but different
for HC; nevertheless, the latent variables shared common items across both the patient group and HC. On the contrary, QIDS
had overall very different principal components across groups; sleep was a key element in HC and BD but was absent in BPD.
In GAD-7, nervousness was the principal component explaining most of the variance in BD and HC.
Conclusions: This study has important implications for understanding self-reported mood. MZ has a consistent, intuitively
interpretable latent variable structure and hence may be a good instrument for generic mood assessment. Irritability appears to
be the key distinguishing latent variable between BD and BPD and might be useful for differential diagnosis. Anxiety and sadness
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are closely interlinked, a finding that might inform treatment effects to jointly address these covarying symptoms. Anxiety and
nervousness appear to be amongst the cardinal latent variable symptoms in BD and merit close attention in clinical practice.
(JMIR Ment Health 2017;4(2):e15)   doi:10.2196/mental.6917
KEYWORDS
bipolar disorder; borderline personality disorder; depression; mania; latent variable structure; mood monitoring; patient reported
outcome measures; mhealth; mobile app
Introduction
Regular monitoring of symptom severity and disease progression
in mental disorders is widely encouraged in treatment guidelines
[1,2]. This had been typically achieved using patient reported
outcome measures (PROMs), that is, self-assessment of mood
on standardized questionnaires. Originally, questionnaires were
paper-based and more recently computer-based [3,4]; however,
recent technological developments have generated considerable
interest in capitalizing the wide availability of smartphones to
embed questionnaires in purpose-built apps [5-9]. This approach
has advantages because mood self-assessment is reported in
real time alleviating the issue of recall bias [10].
One approach toward PROMs is to develop generic instruments
capturing universal outcomes that are relevant across a wide
range of diseases and conditions such as pain and fatigue. This
motivated the development of the patient reported outcomes
measurement information system (PROMIS), an instrument for
self-reporting physical, mental, and social health aspects in the
general population [11-13]. Some associated toolbox measures
have been developed using the item banks within PROMIS to
cover specific populations, for example, those diagnosed with
a neurological condition or disorder [14]. Universal measures
such as PROMIS are undoubtedly useful for large-scale studies
facilitating direct comparisons across diverse cohorts and
diseases; however, by design, they are not necessarily sensitive
to capturing all the intricate symptom changes of specific
diseases. The alternative approach to generic instruments is to
develop tailored disease-specific (also known as
disease-attributed) instruments that may be of particular
significance from a clinician’s perspective for effective
assessment and monitoring of symptoms within a specific
disease or condition. Both universal PROMs and disease-specific
PROMs have merits and shortcomings, and the decision to use
either approach depends upon the aims of a study.
In this study, we focus on mining PROMs using disease-specific
clinical scales to better understand the underlying symptoms in
bipolar disorder (BD) and borderline personality disorder (BPD),
comparing findings against healthy controls (HC). BD is
characterized by recurrent alternating periods of elated mood
(known as mania or hypomania, depending on symptom
severity) and depression, which is usually more common [15].
Symptom-free periods in BD are known as euthymia. Symptom
management is typically achieved using long-term medication
[16], including mood stabilizers and antipsychotics [15]. BPD
is characterized by splitting (failing to form a cohesive whole
taking into account positive and negative traits for self and
others), impulsivity, irritability, negative criticism, difficulty to
regulate emotions, depression, anxiety, and anger [17]. The
dominant treatment modality is psychotherapy although
pharmacotherapy is common in clinical practice. BD and BPD
can be clearly distinguished using laboratory measures of social
cooperation and reward learning [18] but in clinical practice
their distinction can be far more challenging because of the
overlap in the diagnostic criteria. Correct diagnosis is critical
given the divergent treatment approaches. Mood monitoring is
commonly used in both clinical groups although the
interpretation of their mood scores has often been challenged
as positive responses are thought to reflect very different
underlying psychological processes.
A critical aspect of understanding PROMs is deciphering the
underlying structure inherent in the questionnaires eliciting the
participants’ responses. That is, identifying some characteristics
(latent variables) which are not directly observed through the
items in the questionnaires but which are inferred through
algorithmic processing of the observed items. One of the main
advantages of using latent variables is explaining most of the
data using a few variables which may be tentatively
interpretable. They comprise items grouped together, thus
indicating which different symptoms may be related. Hence,
latent variables might offer additional insight into the underlying
mood symptoms, and suggest new directions for clinical
assessment and care.
The aims of this study were to: (1) explore the latent variable
structure of a recently introduced psychiatric questionnaire
known as Mood Zoom (MZ) [9] to understand better its
properties and internal structure, (2) identify differences in the
latent variables of the MZ questionnaire for the three studied
cohorts (BD, BPD, and HC) and observe how well they
differentiate the patient cohorts and benchmark findings against
HC, and (3) explore three other widely used psychiatric
questionnaires and identify their internal consistency across
cohorts and their potential similarities with MZ.
Methods
Data
The data were collected as part of a large ongoing research
project known as automated monitoring of symptom severity
(AMoSS) [9]. We record mood, activity, and physiological
variables using a variety of sensors [19,20]. The study is
observational and independent of participants’ clinical care: we
recruited 141 participants, and their demographic details are
summarized in Table 1. The participants were recruited for an
initial 3-month study period, with an option to remain in the
study for 12 months or longer. The patient cohorts were mainly
recruited from other ongoing studies in Oxfordshire or from
individuals who had previously registered interest to be involved
JMIR Ment Health 2017 | vol. 4 | iss. 2 | e15 | p.2http://mental.jmir.org/2017/2/e15/
(page number not for citation purposes)
Tsanas et alJMIR MENTAL HEALTH
XSL•FO
RenderX
in future research; in particular, some of the BD participants
have had multiple years of experience in mood self-reporting.
The age-matched HC were recruited by means of advertising
in commonly used forums locally.
We excluded data from participants who either withdrew consent
(1 participant) or completed participation without providing at
least two months of useful data for all questionnaires (9
participants). We processed data from 131 participants, 120 of
whom had provided data for at least three months, and 108 of
whom had provided data for at least 12 months. All participants
gave written informed consent to participate in the study. All
patient participants were screened by an experienced psychiatrist
(KEAS) using the structured clinical interview for diagnostic
and statistical manual of mental disorders, 4thedition (DSM IV)
and the borderline items of the international personality disorder
examination (IPDE) [21]. The study was approved by the NRES
Committee East of England- Norfolk (13/EE/0288) and the
research and development department of Oxford Health NHS
Foundation Trust.
Questionnaires for Mood Self-Monitoring
The participants reported their mood on a weekly basis using
three validated questionnaires: (1) Altman self-rating mania
scale (ASRM) [22] to assess mania, (2) quick inventory of
depressive symptomatology (QIDS) self-report [23] to assess
depression, and (3) generalized anxiety disorder (7-item)
(GAD-7) [24] to assess anxiety. These three questionnaires were
completed on the Web using the true colors (TC) system: the
participants had been previously registered on the website and
would need to provide their log in credentials to securely connect
to their TC page. In all cases, the participants were requested
to complete ASRM, QIDS, and GAD-7 reporting the average
symptoms during the preceding week. The MZ questionnaire
[9] was completed on a daily basis using a custom-based
smartphone app developed for the needs of the AMoSS project.
ASRM is comprised of 5 items: (1) mood, (2) self-confidence,
(3) sleep disturbance, (4) speech, and (5) activity. Items are
scored on a 0 (symptom-free) to 4 (present nearly all the time)
scale, and the total ASRM is computed by adding up the items
in the 5 sections giving rise to the range 0 to 20. Miller et al
[25] proposed a cut-off score of 5.5 assess a manic episode.
QIDS is comprised of 16 items, where each item is scored on
a 0 (symptom-free) to 3 scale. The items map onto 9 DSM-IV
symptom criteria domains for depression: (1) sad mood, (2)
concentration, (3) self-criticism, (4) suicidal ideation, (5) loss
of interest, (6) energy or fatigue, (7) sleep disturbance, (8)
changes in appetite or weight, and (9) psychomotor agitation
or retardation. Each domain is either the highest score of a subset
of the 16 QIDS items or one of the original QIDS items; see
Rush et al for details [23]. Each domain contributes 0-3 points,
and adding up these domains gives rise to the QIDS total score
ranging from 0 to 27. The suggested clinical ranges are 5 or less
denoting normal, 6-10 denoting mild depression, 11-15 denoting
moderate depression, 16-20 denoting severe depression, and
21-27 denoting very severe depression [23,26].
GAD-7 is comprised of 7 items which are scored on a 0
(symptom-free) to 3 (nearly every day) scale, with total scores
ranging from 0 to 21. Kroenke et al [27] endorsed using the
threshold cut-offs at 5, 10, and 15 to denote mild, moderate,
and severe anxiety, respectively.
MZ is comprised of 6 items: (1) anxious, (2) elated, (3) sad, (4)
angry, (5) irritable, and (6) energetic. Each item is scored on a
Likert scale ranging from 1 (“not at all”) to 7 (“very much”).
Participants were prompted to complete MZ during the study
daily in the evening at a prespecified chosen time.
Samples Used for the Four Questionnaires
We constructed 4 data matrices to contain the data for
subsequent processing, one data matrix for each of the
questionnaires. Subsequently, we worked independently on each
of those 4 matrices to determine properties applicable to each
of the questionnaires.
For ASRM we used a 5719×5 data matrix. There were 2363
samples for BD, 1298 samples for BPD, and 2058 samples for
HC.
For QIDS we used a 4871×9 data matrix. There were 2054
samples for BD, 1099 samples for BPD, and 1718 samples for
HC.
For GAD-7 we used a 5652×7 data matrix. There were 2208
samples for BD, 1389 samples for BPD, and 2055 samples for
HC.
For MZ we used a 44725×6 data matrix (44725 samples and 6
items). There were 17317 samples for BD, 11120 samples for
BPD, and 16288 samples for HC.
Any missing entries (~20% as we reported in our previous study
[9]) had been removed before reporting these figures.
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Table 1. Summary of the key demographics of participants in automated monitoring of symptom severity (AMoSS).
Healthy controlsBorderline personality disorderBipolar disorder
543453Originally recruited
513248Processed data from
363 (191; 80-651)364 (194; 81-858)365 (325; 69-867)Days in study, median (IQRarange)
37 (20; 19-63)34 (14 21-56)38 (19; 18-64)Age (years), median (IQR range)
18217Gender (male)
6157Unemployed
02347Any psychotropic medication
0019Lithium
0119Anticonvulsant
0633Antipsychotic
02317Antidepressants
023Hypnotics
aIQR: interquartile range.
Data Preprocessing
Before processing the data, we standardized entries to reflect
individual reporting bias so that they are directly comparable
across participants. This preprocessing step was deemed
necessary because the same level of mood may be assigned a
different item score by different participants, and hence the raw
item scores are not directly comparable across participants.
Therefore, for each questionnaire, we subtracted from each item
entry the mean value of that item per participant. Effectively,
this transformed the discrete data matrices into continuous data
matrices. This step is particularly useful in combination with
the latent variable structure approach described below.
Extracting Latent Variable Questionnaire Structure
Using Sparse Principal Component Analysis
Given a data matrix X N × M that is, a collection of the
questionnaire entries comprising N samples (observations) and
M variables (for this study M is the number of items of the
investigated questionnaire), we wanted to obtain its internal
structure, which is potentially governed by some unseen
variables. That is, we wanted to project the information inherent
in the original items in such a way that we could identify a
robust set of some new variables that might offer new or
alternative insights into the hidden structure in the data, that is,
identify the latent variables.
The mathematical approaches to achieve this can be generally
divided into linear and nonlinear methods, depending on how
the original variables in the data matrix are combined to derive
the latent variables. Although sophisticated nonlinear methods
may work well in complicated toy problems, they are often
more difficult to interpret than some standard linear projection
techniques (which in many practical settings may also work
very well). One of the most widely used methods for detecting
the latent variable structure of a data matrix is principal
component analysis (PCA) [28]. PCA computes linear
combinations of the M variables, known as principal
components. The principal components are projected in
orthogonal directions (hence, they are linearly uncorrelated)
and successively explain the largest possible remaining variance
in the data. The coefficients each variable in X contributes
toward predicting the principal components are known as the
loadings. The PCA structure looks like the following:
P1= l11⋅x1+ l12⋅x2+ l13⋅x3+ … + l1M⋅xM
P2= l21⋅x1+ l22⋅x2+ l23⋅x3+ … + l2M⋅xM
…
PM= lM1⋅x1+ lM2⋅x2+ lM3⋅x3+ … + lMM⋅xM
In the equation, P1… PM are the principal components, x1… xM
are the items in each questionnaire, and lij refers to the loading
of the j th item contributing toward the computation of the i th
principal component (and all the lij entries form the loading
matrix L). Usually, we only want to work on the first few
principal components, which explain most of the variance in
the data.
In practice, each principal component is a linear combination
of all the original variables; that is, the loadings are generally
non-zero, and therefore the interpretation of the resulting
principal components may be challenging. Ideally the structure
(ie, collectively the loadings) should be simple, comprising a
few non-zero entries associating a small subset of the variables
in subset of the X with the principal components, and still
maximizing as much of the explained variance in the data as
possible. Hence, researchers have developed various sparse
PCA (SPCA) approaches to promote principal components that
are dependent only on a small set of variables in the original
data matrix. Inherently, there is a compromise to be made
between the interpretability of the principal components and
the explained variance [29-32].
In this study, we followed the methodology proposed in Hein
and Buehler [32] tocompute SPCA using an L1-based
regularization to minimize the number of contributing items
toward each principal component. The compromise between
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the cardinality (number of contributing items in each principal
component) versus the explained variance was optimized using
trial and error in order to obtain principal components that
explained as much of the variance as possible, while still being
easily interpretable.
Density Plots and Statistical Hypothesis Testing
We computed the densities using kernel density estimation with
Gaussian kernels to visualize the differences in the latent
variables for the three cohorts and used the 2-sample
Kolmogorov-Smirnov goodness-of-fit statistical hypothesis test
to determine whether the distributions are statistically
significantly different. We tested the null hypothesis that the
random samples are drawn from the same underlying continuous
distribution.
Differentiating Cohorts Using Divergence Metrics
Next, we wanted to quantify the difference in the distributions
of the principal components for the different groups. The
computation of effect sizes is one widely used approach to
quantify these differences, but relies on having Gaussian
distributions which is not necessarily the case here. A more
generic methodology to quantify differences between two
distributions relies on the divergence metrics [33,34]. The
divergence metrics make no strong hypotheses about the
underlying distributions (primarily that they exist and are
continuous) and can be thought of as robust approaches to
measure how much two distributions differ. Here, we report the
commonly used symmetric Kullback-Leibler divergence to
quantify differences between two distributions. The distributions
were computed using kernel density estimation with Gaussian
kernels.
Results
Latent Variable Questionnaire Structure
Table 2 presents the latent variable structure for the MZ
questionnaire using the standard PCA. The tentative labeling
of the resulting principal components was driven by the
members of the AMoSS team with clinical background and
decided by consensus from all authors. The presence of non-zero
loadings for all items obstructs the clear interpretation of the
underlying meaning of the principal components. For example,
the first principal component for BD and BPD could be
tentatively interpreted as “negative affect” since the MZ items
with a negative connotation tend to dominate; nevertheless,
there is non-negligible contribution by all items thus
complicating the task of understanding the latent variable
meaning. Similarly, the second principal component could be
considered to denote the “positive affect” since the 2 key items
with large loadings denote positive feelings; nevertheless, there
is some nonnegligible contribution from the remaining items.
Moreover, it is not easy to interpret the third principal
component (henceforth, when a latent variable cannot be
interpreted in a simple term, it is left blank). These findings
motivated the search for computing sparse principal components.
In Table 3 we present the findings using SPCA, which leads to
more interpretable latent variables. We note that in this case the
results are more intuitively understandable compared with Table
2, since the loading matrix comprises many non-contributing
items toward the computation of the principal components.
Crucially, the principal components are identical for the 3 groups
(with different order), supporting the concept of a coherent
internal MZ latent variable structure in the study of the 3 cohorts
investigated here. Furthermore, the results reported using SPCA
in Table 3 provide further intuitive understanding into the key
latent variables of Table 2; essentially, the “negative affect”
was decomposed into its two constituents, “anxiety and sadness”
and “irritability,” while the “Positive affect” seen in Table 2
remained unaffected. Finally, the order of the principal
components for each of the 3 cohorts is revealing about the
latent variables which are most predictive in each case: for the
patient cohorts, anxiety and sadness appears to be the most
important mood symptom characteristic, whereas in HC most
of the variance is explained using the “positive affect.”
Next, we applied SPCA on ASRM (Table 4), QIDS (Table 5),
and GAD-7 (Table 6). The aim was to determine how stable
the latent variables of each questionnaire are across groups, and
determine whether there are some latent variables common
across the investigated questionnaires and MZ.
The latent variable structure of ASRM is not consistent across
the 3 groups, but it is consistent for the psychiatric groups. Some
of the computed latent variables are not easily interpretable: for
example, it is not clear how we should interpret the latent
variable consisting of the items “sleepy” and “talkative.” The
“positive affect” in the ASRM latent variable reported in Table
4 for BD and BPD appears to be very similar with the “positive
affect” reported in Table 3 for MZ. This is a finding that could
have been reasonably expected on the basis of the key items
identified for the 2 questionnaires. In general, the HC
participants in AMoSS did not exhibit manic episodes and their
ASRM variability was very low. Thus, the findings for the HC
group should be interpreted very cautiously as possibly due to
lack of data.
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Table 2. Mood zoom (MZ) latent variable structure using standard principal component analysis (PCA).
P3P2P1MZ item
Bipolar disorder
0.810.100.52Anxious
0.070.72−0.19Elated
−0.050.090.49Sad
−0.440.170.45Angry
−0.380.190.47Irritable
0.030.63−0.19Energetic
84.677.257.8% total variance explained
Positive affectNegative affectTentative interpretation
Borderline personality disorder
0.39−0.010.51Anxious
0.240.70−0.13Elated
0.56−0.240.48Sad
−0.360.240.48Angry
−0.490.270.51Irritable
0.320.58−0.07Energetic
81.269.648.9% total variance explained
Positive affectNegative affectTentative interpretation
Healthy controls
−0.060.570.18Anxious
−0.63−0.230.74Elated
−0.020.500.15Sad
0.030.370.12Angry
0.050.460.12Irritable
0.77−0.170.61Energetic
87.878.251.7% total variance explained
Negative affectPositive affectTentative interpretation
JMIR Ment Health 2017 | vol. 4 | iss. 2 | e15 | p.6http://mental.jmir.org/2017/2/e15/
(page number not for citation purposes)
Tsanas et alJMIR MENTAL HEALTH
XSL•FO
RenderX
Table 3. Sparse mood zoom (MZ) latent variable structure.
P3P2P1MZ item
Bipolar disorder
000.75Anxious
0−0.640Elated
000.66Sad
0.6200Angry
0.7900Irritable
0−0.770Energetic
75.856.633.1% total variance explained
IrritabilityPositive affectAnxiety and sadnessTentative interpretation
Borderline personality disorder
000.66Anxious
−0.7100Elated
000.75Sad
00.670Angry
00.740Irritable
−0.7000Energetic
74.754.931.5% total variance explained
Positive affectIrritabilityAnxiety and sadnessTentative interpretation
Healthy controls
00.730Anxious
00−0.66Elated
00.680Sad
−0.5900Angry
−0.8100Irritable
00−0.75Energetic
73.558.937.9% total variance explained
IrritabilityAnxiety and sadnessPositive affectTentative interpretation
QIDS appears to have a very inconsistent structure when
examined with SPCA. In most cases, it is not easy to interpret
what the resulting principal components mean; this may reflect
that the QIDS items are disjoint, and there is no clear underlying
latent variable structure.
GAD-7, like QIDS, is not very consistent across the 3 cohorts.
Moreover, some of the resulting latent variables are difficult to
interpret, for example, the meaning of the principal component
comprised of the items “relaxed” and “restless.” Nevertheless,
some of the latent variables across cohorts are consistent: the
latent variable “nervousness” explains most of the variance in
HC and BD. This is effectively the equivalent latent variable of
MZ “anxiety and sadness” in Table 3.
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Table 4. Sparse Altman self-rating mania (ASRM) scale latent variable structure.
P3P2P1ASRM item
Bipolar disorder
−0.4500.65Happy
−0.8900Confident
00.920Sleepy
00.380Talkative
000.76Active
8269.150.1% total variance explained
AssertivenessSleepy and talkativePositive affectTentative interpretation
Borderline personality disorder
−0.5800.57Happy
−0.8100Confident
00.880Sleepy
00.470Talkative
000.82Active
80.96747.4% total variance explained
AssertivenessSleepy and talkativePositive affectTentative interpretation
Healthy controls
000.90Happy
000.44Confident
000Sleepy
−0.950.310Talkative
0.310.950Active
79.966.239.7% total variance explained
Quiet and activeActive and talkativeAssertivenessTentative interpretation
Differentiating Cohorts
We investigated whether the principal components could
differentiate the 3 cohorts in the study, BD, BPD, and HC. Since
only MZ has a consistent latent variable structure across all 3
cohorts, the comparisons are only reported for that questionnaire
in Table 7.
The densities of the principal components for the 3 cohorts are
presented in Figures 1,2, and 3. In all cases, we found that the
2-sample Kolmogorov-Smirnov test rejected the null hypothesis
that the samples were drawn from the same distribution, for all
comparisons (P=0.001) this verifies the results expected
following visual inspection of the densities.
We summarized the MZ latent variable values and quantified
the differences between pairs of distributions using the
symmetric Kullback-Leibler divergence in Table 7.
Overall, the findings in Table 7 suggest that the computed sparse
principal components can adequately differentiate cohorts for
all pairwise comparisons. We remark that the “irritability”
principal component leads to clearer separation visually, a
finding which is also reflected in the divergence values reported
in Table 7. These results suggest that “irritability” swings may
be one of the crucial differentiating factors between these 2
psychiatric cohorts.
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Table 5. Sparse quick inventory of depressive symptomatology (QIDS) self-report latent variable structure.
P3P2P1QIDS item
Bipolar disorder
0−0.960Sleep
00−0.72Sad
−0.9800Appetite or weight
000Concentration
00−0.69Self-view
000Suicide
000Interest
−0.2200Energy
0-0.280Restless
68.450.430.2% total variance explained
Appetite and energySleep changesEsteem and sadnessTentative interpretation
Borderline personality disorder
000Sleep
000Sad
0−0.940Appetite or weight
000Concentration
0.8900Self-view
0.4500Suicide
00−0.78Interest
00−0.62Energy
0−0.330Restless
6850.331.2% total variance explained
Self-esteem and suicideAppetite and restlessnessEnergeticTentative interpretation
Healthy controls
00−0.99Sleep
−0.8300Sad
0−0.960Appetite or weight
000Concentration
−0.5500Self-view
000Suicide
000Interest
0−0.29−0.15Energy
000Restless
7659.737.9% total variance explained
Esteem and sadnessAppetite and energySleepTentative interpretation
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Table 6. Sparse generalized anxiety disorder 7 (GAD-7) latent variable structure.
P3P2P1GAD-7 item
Bipolar disorder
00−0.75Nervous or anxious
00−0.67Control worries
000Worried
0.54−0.370Relaxed
0.8400Restless
0−0.930Irritable
000Afraid
72.960.541.2% total variance explained
ActivityIrritability and relaxationNervousnessTentative interpretation
Borderline personality disorder
000Nervous or anxious
−0.7100Control worries
−0.7000Worried
000.63Relaxed
000.78Restless
00.810Irritable
00.580Afraid
69.848.429.3% total variance explained
WorryIrritability and fearActivityTentative interpretation
Healthy controls
000.81Nervous or anxious
0.4600.58Control worries
0.89−0.230Worried
000Relaxed
000Restless
0−0.970Irritable
000Afraid
73.559.936.2% total variance explained
WorryIrritability and worryNervousnessTentative interpretation
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Table 7. Summary statistics for the sparse principal components computed in Table 3, and symmetric Kullback-Leibler divergence for pairwise
comparisons across the 3 groups (BD, BPD, HC).
BPD versus HC
(divergence)
BD versus HC
(divergence)
BD versus BPD
(divergence)
HCc
Median (IQR)
BPDb
Median (IQR)
BDa
Median (IQRd)
Sparse principal component
Mood Zoom
4.724.461.78−0.08 (0.63)−0.12 (2.56)−0.16 (1.89)P1e
1.250.971.150.03 (1.29)0.11 (1.98)0.16 (1.60)P2f
6.783.173.67−0.05 (0.34)−0.16 (2.31)−0.27 (1.47)P3g
aBD: bipolar disorder.
bBPD: borderline personality disorder.
cHC: healthy controls.
dIQR: interquartile range.
eP1= “anxiety and sadness.”
fP2= “positive affect.”
gP3= “irritability.”
Figure 1. Density estimates of the “anxiety and sadness” principal component for the three cohorts.
Figure 2. Density estimates of the “positive affect” principal component for the three cohorts.
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Figure 3. Density estimates of the “irritability” principal component for the three cohorts.
Discussion
Principal Findings
We have applied a recently developed form of SPCA to explore
the latent variables of four psychiatric questionnaires across
BD, BPD, and HC. We emphasize that the SPCA used here was
guided primarily by the need to develop simple latent variables
that would facilitate interpretation over and above findings
computed using the standard PCA. As expected, in most cases
the loadings in the patient cohorts were more similar compared
with HC. The latent variable structure was stable across all three
cohorts for MZ and stable across the patient cohorts for ASRM.
On the contrary, the latent variable structure was quite different
for the three cohorts for QIDS and GAD-7. Broadly speaking,
having the same latent variables across cohorts indicates internal
consistency of a questionnaire and is a convenient property
because it enables direct quantitative comparisons of the
resulting latent variables (see Table 7). On the other hand,
having different resulting latent variables across cohorts could
lead to the identification of the most prominent mood item
cluster constellations in each case.
The recently proposed MZ [9] can be described in terms of three
latent variables which can be tentatively interpreted as (1)
anxiety and sadness, (2) irritability, and (3) positive affect. These
three latent variables explain about 75% of the variance (Table
3), which is consistent across the three studied cohorts (BD,
BPD, and HC). Moreover, the anxiety and sadness principal
component explains most of the variance for the BD and BPD
cohorts, while the positive affect explains most of the variance
for HC. Similarly, the primary latent variable in GAD-7 for BD
was “nervousness.” Thus, BD participants are strongly affected
by anxiety, which is known to be a common comorbid factor
[35]; this further supports the argument that anxiety should be
customarily monitored longitudinally in addition to the
cornerstone mania and depression symptoms [17]. However,
the first two MZ latent variables appear to have considerable
overlap between the psychiatric groups. The latent variable that
differentiates BD from BPD best is “irritability” (see Table 7).
Our findings suggest that BPD participants exhibit considerably
larger irritability variability compared with BD participants.
Further work is required to investigate how this finding might
be used by psychiatrists in the challenging setting of differential
diagnosis between the 2 groups [36].
The latent variable structure of ASRM was identical for BD
and BPD but differed when compared with HC; this may
indicate that the psychiatric groups have the same underlying
effects when reporting mania symptoms. However, we view
this finding very cautiously, because the ASRM variability was
extremely low for HC. Sleep appears to be a key item in the
latent variables of QIDS for HC and BD but not BPD. This
might reflect a true difference in the perception of the effect of
sleep on mood symptoms in BPD; again, this finding should be
treated with caution because most BPD participants in the study
were unemployed and hence, this may have skewed their
responses.
It is difficult to cross-reference the questionnaires since they
have been fundamentally developed to capture different mood
symptoms (ASRM for mania, QIDS for depression, and GAD-7
for anxiety). Nevertheless, we have seen that irritability is a key
latent variable in MZ, and that item dominates the second latent
variable in GAD-7. Similarly, “anxiety and sadness” is the
primary latent variable of MZ, which is similar to the first latent
variable observed for BD and HC in GAD-7 (Table 6). To test
whether we can obtain cross-referenced latent variables among
questionnaires, we merged ASRM, QIDS, and GAD-7 in a
single dataset and applied SPCA for each of the three cohorts
(results not shown). In almost all cases, the latent variables
computed were clustered within the items of the same
questionnaire and were typically dominated by QIDS items,
with findings similar to those reported in Table 6. This suggests
that depression-related symptoms explain most of the variance
overall across the three questionnaires, a finding which is in
agreement with the BD literature [15].
Understanding and interpreting the latent variables may have
important implications for understanding mood traits and mood
trait interactions and could lead into new hypotheses and clinical
research insights. We found that anxiety and sadness are mood
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characteristics that covary consistently across groups (Table 3)
indicating they are comorbid symptoms [37], and corroborating
contemporary clinical practice treatment approaches often jointly
addressing both [38]. Similarly, the latent variable comprising
the items “elated” and “energetic” (Table 3) suggests there is a
general underlying feeling of positive affect linking euphoria
and energy. Crucially, this latent variable was found to be
explaining most of the variance in the data for HC but not for
the patient groups. The last MZ latent variable comprises the
“angry” and “irritable” items, in line with results reported by
Pasquini et al [39] who studied major depressive disorder using
a very different clinical scale and processed their data using
factor analysis to derive the same component. The current
study’s results generalize their main conclusion that psychiatrists
should be aware of the relevance of this dimension in assessment
and treatment of BD and BPD. The latent variable which we
called “assertiveness” (Table 4) indicates that the “happy” and
“confident” items cluster together across all three cohorts and
is particularly prominent in HC explaining most of the variance.
This finding may have wider implications suggesting that
increasing someone’s perceived happiness may also boost
confidence. We also reported on a latent variable comprising
sadness and low self-esteem (Table 5), which is common in BD
and HC; some studies have empirically linked depleted
self-esteem with increased depressive symptoms [40]. The
corresponding latent variable for BPD comprises the intricately
intertwined “self-esteem” and “suicide” items; hence, low
self-esteem may have considerably more severe consequences
for this patient group compared with BD, suggesting experts
may need to be particularly vigilant in the morale of their BPD
patients. Finally, in Table 6 the irritability item dominates the
second latent variable of GAD-7 in all cohorts; however, it is
grouped with a different item in each case: (1) “relaxation” for
BD, (2) “fear” for BPD, and (3) “worry” for HC. Hence, the
mood trait expressed in the “angry” item in MZ appears to act
as an umbrella term capturing different mood aspects that appear
in GAD-7 for each of the three cohorts.
Comparison With Prior Work
We have presented results from a relatively large number of
participants in the context of longitudinal mood monitoring,
tracking their mood variation for multiple months as opposed
to other studies, which were confined to a few weeks (eg,
[7,41]). Moreover, we elicited answers to multiple
questionnaires, whereas most studies had focused on a single
questionnaire to investigate symptom variation, for example,
depression [41-43]. Additionally, most other studies focus solely
on a single disorder, for example, BD [5,41-43], whereas we
have also recruited people diagnosed with BPD and compared
findings against HC.
There is a large number of PROMs developed for (1) the general
population, (2) broad population cohorts (eg, people diagnosed
with mental disorders), and (3) specific disorders such as BD.
Well-known generic instruments include the profile of moods
state (POMS) [44] and the positive and negative affectivity
schedule (PANAS) [45]. The full-length form of POMS
comprises 65 items whereas the short form comprises 35 items
[44]; the user would likely need 5-10 min to complete these.
Based on the original items, POMS computes the participant’s
mood profile comprising the following mood dimensions: (1)
anger-hostility, (2) confusion-bewilderment, (3)
depression-dejection, (4) fatigue-inertia, (5) tensor-anxiety, (6)
vigor-activity, and (7) friendliness. Although these seven
dimensions bear similarities with the 6 MZ items, we emphasize
that the two methods actually exhibit some differences in terms
of the mood profiles assessed, and more importantly have very
different approaches at how these mood characteristics are
computed. They are evaluated directly on a 7-point Likert scale
in MZ, whereas they are computed in POMS from the originally
35 or 65 items, each of which is rated on a 5-point Likert scale.
PANAS comprises 20 items in total (10 for positive affect, 10
for negative affect), each of which is rated on a 5-point Likert
scale. Again, although there is some overlap in terms of the
items used in PANAS and MZ, the two methods are different
both in terms of the actual items used (for example PANAS
does not include the MZ items “anxious” and “sad”) and also
in terms of the Likert scale length (5-point for PANAS).
Therefore, MZ has subtle but important differences when
compared with POMS and PANAS. The major advantage of
MZ is that it is a very compact questionnaire developed
primarily to capture the main mood swings in BD and BPD,
while at the same time fitting a smartphone screen [9]. Thus,
its completion takes only a couple of seconds, which is likely
a critical aspect when requesting participants to fill in a
questionnaire daily and longitudinally, and it is probably one
of the reasons it was well-received and led to over 80%
long-term adherence [9].
Alternative specialized PROM instruments such as the young
mania rating scale (YMRS) [46] to assess mania symptoms and
patient health questionnaire-9 (PHQ-9) [47] to assess depressive
symptoms have been used in some related studies. It is difficult
to argue which measure is more appropriate in either case. The
use of ASRM and QIDS in this study over YMRS and PHQ-9
reflects more a pragmatic legacy approach; many of the BD
participants in the AMoSS study have been recruited from a
larger study where they have been reporting ASRM and QIDS
for several years (in some cases more than 7 years) as part of
the Oxford NHS TC system. Therefore, at the beginning of the
study, we decided to continue using these questionnaires that
will enable long-term BD monitoring on the same clinical scales
and might provide further insight into seasonality effects and
long-term symptom changes.
Clinical diagnosis of mental disorders has traditionally relied
on conventional DSM guidelines, which is a symptom-based
approach. A relatively recently proposed framework for studying
mental disorders is the research domain criteria (RDoC), which
aims to provide a more inclusive, multidimensional approach
including genetic, neural, and behavioral features [48]. One of
the RDoC dimensions is “self-reports” (interview scales,
questionnaires) and is assessed on items comprising the latent
categories “negative valence” (anxiety, fear) and “positive
valence” (motivation, responsiveness). Therefore, there is some
overlap in the computed MZ latent variables and the suggested
RDoC self-reports dimension. We remark that the RDoC was
conceived as a diagnostic category agnostic framework to be
adapted by researchers based on their needs, proposing a
continuum of assessment rather than a categorical-based
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assessment. This study’s findings could be used to inform the
self-reports dimension of the RDoC, particularly since we found
the MZ latent variables to be stable across the psychiatric cohorts
and HC.
Although some previous studies have studied the internal
consistency of psychiatric questionnaires [49,50], to the best of
our knowledge, no study has investigated the internal structure
of different questionnaires across psychiatric groups using SPCA
to obtain interpretable latent variables. One method that has
often been successfully used to compute latent variables in the
field of psychiatry is item response theory (IRT), for example,
see Rush et al [23]. Mathematically, IRT operates on discrete
data; however, since we process datasets comprising attributes
in the continuous domain, the implicit assumptions for using
IRT are not valid.
In a recent previous study [9], we had introduced MZ and used
PCA to investigate its properties. We had reported two principal
components across the three cohorts (BD, BPD, and HC), which
we referred to as “negative MZ” and “positive MZ.” The
presence of a positive affect and negative affect had been
previously described in studies of normal emotion in psychology
[51]. This study’s findings provide further insight into the
“negative affect” MZ; it can be further decomposed into two
components, which we interpret as “anxiety and sadness” and
“irritability.”
Limitations
Notwithstanding the relatively large number of participants for
the studied patient groups, there were certain limitations. First,
we used three widely established questionnaires used for
self-assessment of mood symptoms (ASRM, QIDS, and GAD-7)
and the recently proposed MZ. There are numerous other
questionnaires in the psychiatric literature, some of which have
also been used in the context of BD.
Second, most of the BD participants were recruited from a larger
study; therefore, they might be more compliant than a new
cohort in this diagnostic group. However, we stress that
participants were originally recruited for 3 months with the
option to stay longer; the majority found the study engaging
and provided data for at least a year. Although the study cohort
was representative of a subgroup of psychiatric outpatients, it
did not include those who were psychotic or who had significant
comorbidities. Moreover, the vast majority of the BD cohort
was euthymic for the larger part of the AMoSS study with very
few participants exhibiting the characteristic alternating periods
of mania and depression. Future studies could investigate
differences within BD to compare questionnaire latent variable
structures and loadings of a euthymic subgroup versus a
subgroup cycling through mania and depression.
Third, the study was observational in nature, and we had very
little contact with participants. The pharmacological treatment
at trial onset was recorded, but we do not have accurate
information on changes in medication through the duration of
the study. All the reported scores rely on self-assessment; there
is a lack of ongoing clinical assessment by experts to validate
the findings. For example, Faurholt-Jepsen et al [52], in a
meta-analysis study, reported that self-reported measures on
mania may not be reflective of the true clinical condition.
Finally, there are multiple machine learning techniques to
determine the latent variable structure of the data. In addition
to different types of SPCA with different penalties and
regularization settings, there are alternative techniques such as
factor analysis, non-negative matrix factorization, and more
complicated manifold embedding methods [28,53]. Ultimately,
all these algorithms need to balance between the explanatory
power and the interpretability of the computed latent variables.
Future studies could investigate further into more complicated
schemes and latent variable structures.
We tried to identify the underlying psychological processes for
the three cohorts by interpreting the latent variables computed
from a single modality: self-assessed questionnaires. It could
be argued that using latent variables compared with single items
might be more robust in defining underlying psychological
processes because they rely on multiple items which covary,
and hence these provide a better means to identify differences
between cohorts. Nevertheless, this argument would need to be
validated using additional data looking at more detailed aspects
about how these facets overlap with markers from other
modalities. We have collected a large set of additional modalities
in AMoSS (electrocardiogram, geolocation, activity, sleep, and
social interaction) which we will be exploring in future work.
Ultimately, as suggested in RDoC, mental health is not a
single-dimensional concept, and fusing information from
multiple modalities can bring additional key insights and
improve understanding of the underlying processes and clinical
assessment.
Conclusions
The findings in this study further support the recent introduction
of MZ in clinical psychiatric practice. Its structure in terms of
the first three principal components is consistent across BD,
BPD, and HC, and the order of the principal components can
be tentatively understood intuitively. ASRM is consistent for
the patient groups versus HC. QIDS and GAD-7 are more varied
and do not lead to easily interpretable principal components.
We found that BD and BPD are very similar in terms of some
standardized questionnaires (ASRM) but quite divergent in
terms of QIDS and GAD-7. Further work is warranted to
understand the similarities and differences between BD and
BPD, which may facilitate differential diagnosis and long-term
monitoring of their treatment approaches.
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